These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1822343)

  • 1. Dystrophin abnormalities in polymyositis and dermatomyositis.
    Sewry CA; Clerk A; Heckmatt JZ; Vyse T; Dubowitz V; Strong PN
    Neuromuscul Disord; 1991; 1(5):333-9. PubMed ID: 1822343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal dystrophin in McLeod myopathy.
    Danek A; Witt TN; Stockmann HB; Weiss BJ; Schotland DL; Fischbeck KH
    Ann Neurol; 1990 Nov; 28(5):720-2. PubMed ID: 2260862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T; Stuettgen P; Cremer M; Goebel HH
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of dystrophin in carriers of Duchenne muscular dystrophy.
    Clerk A; Rodillo E; Heckmatt JZ; Dubowitz V; Strong PN; Sewry CA
    J Neurol Sci; 1991 Apr; 102(2):197-205. PubMed ID: 2072119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle.
    Karpati G; Carpenter S; Morris GE; Davies KE; Guerin C; Holland P
    J Neuropathol Exp Neurol; 1993 Mar; 52(2):119-28. PubMed ID: 8440993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spanish family with myalgia and cramps syndrome.
    Sánchez-Arjona MB; Rodríguez-Uranga JJ; Giles-Lima M; Fernández-García R; Chinchón-Lara I; Antiñolo G; Bautista-Lorite J
    J Neurol Neurosurg Psychiatry; 2005 Feb; 76(2):286-9. PubMed ID: 15654055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical analysis of dystrophin in congenital muscular dystrophy.
    Arikawa E; Ishihara T; Nonaka I; Sugita H; Arahata K
    J Neurol Sci; 1991 Sep; 105(1):79-87. PubMed ID: 1795174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
    Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
    Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies.
    Helliwell TR; Man NT; Morris GE; Davies KE
    Neuromuscul Disord; 1992; 2(3):177-84. PubMed ID: 1483043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.
    Matsumura K; Tomé FM; Ionasescu V; Ervasti JM; Anderson RD; Romero NB; Simon D; Récan D; Kaplan JC; Fardeau M
    J Clin Invest; 1993 Aug; 92(2):866-71. PubMed ID: 8349821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
    Augier N; Boucraut J; Léger J; Anoal M; Nicholson LV; Voelkel MA; Léger JJ; Pellissier JF
    J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xp21 dystrophin and 6q dystrophin-related protein. Comparative immunolocalization using multiple antibodies.
    Voit T; Haas K; Léger JO; Pons F; Léger JJ
    Am J Pathol; 1991 Nov; 139(5):969-76. PubMed ID: 1951635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical alterations of dystrophin in congenital muscular dystrophy.
    Werneck LC; Bonilla E
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):416-23. PubMed ID: 8540815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal dystrophin expression in patients with limb girdle syndromes.
    Beyenburg S; Zierz S; Arahata K; Mundegar RR; Friedl W; Jerusalem F
    J Neurol; 1994 Feb; 241(4):210-7. PubMed ID: 8195819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y; Nonaka I; Hirai S; Ozawa E
    J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions.
    Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
    Navarro C
    Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy.
    Uchino M; Miike T; Iwashita H; Uyama E; Yoshioka K; Sugino S; Ando M
    J Neurol Sci; 1994 Jul; 124(2):225-9. PubMed ID: 7964876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.
    Connolly AM; Pestronk A; Planer GJ; Yue J; Mehta S; Choksi R
    Neurology; 1996 Mar; 46(3):810-14. PubMed ID: 8618688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.
    Muntoni F; Mateddu A; Cianchetti C; Marrosu MG; Clerk A; Cau M; Congiu R; Cao A; Melis MA
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):26-31. PubMed ID: 8429320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.